Bramlage, Peter 1969-
Bramlage, Peter
Peter Bramlage researcher (ORCID 0000-0003-4970-2110)
VIAF ID: 38153124333624492209 (Personal)
Permalink: http://viaf.org/viaf/38153124333624492209
Preferred Forms
-
- 100 1 _ ‡a Bramlage, Peter ‡d 1969-
- 100 1 _ ‡a Bramlage, Peter ‡d 1969-
- 100 1 _ ‡a Bramlage, Peter ‡d 1969-
- 100 0 _ ‡a Peter Bramlage ‡c researcher (ORCID 0000-0003-4970-2110)
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen | |
Adipositas in der primärärztlichen Versorgung Daten zur Arzneimittelanwendungsforschung | |
An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria | |
Arterielle Hypertonie und Diabetes mellitus in der allgemeinärztlichen Praxis in Sachsen | |
association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry | |
Disease heterogeneity of adult diabetes based on routine clinical parameters at diagnosis: results from the German/Austrian DPV registry | |
DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany | |
Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years – 1-year follow-up from the prospective INDURE registry | |
Effectiveness and safety of switching rapid-acting insulins to insulin glulisine in patients with diabetes: the observational IGLU-S study | |
Evolution of transcatheter aortic valve implantation over 7 years: results of a prospective single-centre registry of 2000 patients in a large municipal hospital (TAVIK Registry) | |
Frequency of albuminuria in primary care: a cross-sectional study | |
Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis | |
Hypertension in Overweight and Obese Primary Care Patients Is Highly Prevalent and Poorly Controlled | |
Identification of predictive factors of diabetic ketoacidosis in type 1 diabetes using a subgroup discovery algorithm | |
Impact of pre-existing comorbidities on outcomes of patients undergoing surgical aortic valve replacement rationale and design of the international IMPACT registry | |
Mechanische und humorale Stimulation von kardialen Myozyten | |
Olmesartan, Amlodipin differenzierte Therapieentscheidung - wann sollten Sie auf eine Fixkombination von ARB plus CCB setzen? | |
Patterns of antihypertensive drug utilization in primary care | |
Real-world‐data of 12‐month adjunct SGLT2‐inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: improved HbA1c without DKA | |
Renal function deterioration in adult patients with type-2 diabetes | |
Repercusiones clínicas de la adherencia del paciente a una combinación a dosis fijas de olmesartán, amlodipino e hidroclorotiazida | |
Short-term external counterpulsation augments cerebral blood flow and tissue oxygenation in chronic cerebrovascular occlusive disease | |
Transcatheter aortic valve implantation at a high-volume center : the Bad Rothenfelde experience | |
Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases |